These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 31210309)
1. JMJD3 enhances invasiveness and migratory capacity of non-small cell lung cancer cell via activating EMT signaling pathway. Zhang Y; Hua PY; Jin CY; Li JD; Zhang GX; Wang B Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4784-4792. PubMed ID: 31210309 [TBL] [Abstract][Full Text] [Related]
2. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway. Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion. Dong YZ; Meng XM; Li GS Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418 [TBL] [Abstract][Full Text] [Related]
4. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2. Tan T; Xu XH; Lu XH; Wang XW Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973 [TBL] [Abstract][Full Text] [Related]
5. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells. Yang J; Du YM; Li B Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
7. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer. Yu DJ; Li YH; Zhong M Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311 [TBL] [Abstract][Full Text] [Related]
8. LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway. Chen QF; Hu CF; Sun K; Lang YP Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4746-4755. PubMed ID: 31210301 [TBL] [Abstract][Full Text] [Related]
9. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer. Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597 [TBL] [Abstract][Full Text] [Related]
10. TRIM38 suppresses migration, invasion, metastasis, and proliferation in non-small cell lung cancer (NSCLC) via regulating the AMPK/NF-κB/NLRP3 pathway. Zhang K; Lin G; Nie Z; Jin S; Bing X; Li Z; Li M Mol Cell Biochem; 2024 Aug; 479(8):2069-2079. PubMed ID: 37566200 [TBL] [Abstract][Full Text] [Related]
11. LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC. Gao YP; Li Y; Li HJ; Zhao B Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7950-7958. PubMed ID: 31599420 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer. Yu PF; Kang AR; Jing LJ; Wang YM Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):993-1002. PubMed ID: 29509247 [TBL] [Abstract][Full Text] [Related]
13. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer. Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700 [TBL] [Abstract][Full Text] [Related]
14. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer. Yue QY; Zhang Y Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related]
17. LncRNA TRERNA1 promotes malignant progression of NSCLC through targeting FOXL1. Luo DB; Lv HB; Sun XH; Wang Y; Chu JH; Salai AL Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1233-1242. PubMed ID: 32096153 [TBL] [Abstract][Full Text] [Related]
18. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137. Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958 [TBL] [Abstract][Full Text] [Related]
20. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer. Zhang Z; Yang Y; Zhang X Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]